# NG004 in Spinal Cord Injury Patients

> **NCT06817577** · PHASE1 · RECRUITING · sponsor: **NovaGo Therapeutics AG** · enrollment: 21 (estimated)

## Conditions studied

- Acute Spinal Cord Injury (SCI)
- Spinal Cord Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Trauma, Nervous System
- Spinal Cord Injuries (SCI)
- Wounds and Injuries

## Interventions

- **DRUG:** NG004

## Key facts

- **NCT ID:** NCT06817577
- **Lead sponsor:** NovaGo Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-18
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817577, "NG004 in Spinal Cord Injury Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06817577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*